NEW YORK (GenomeWeb) – Scientists this week described a new mechanism by which Cas9 proteins can target viral RNA.

In a paper published in the Proceedings of the National Academy of Sciences, the researchers from Emory University detailed the use of a Cas9 variant from the gram-negative bacterium Francisella novicida that can inhibit viral protein production from hepatitis C virus (HCV) RNA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.